Condition
Recurrent Nasopharynx Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Recurrent Nasopharynx Carcinoma clinical trials that are recruiting, in China. By phase: Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
PD-1 inhibitor plus chemotherapy followed by immediate versus selective re-irradiation for locally advanced recurrent nasopharyngeal carcinoma
This phase II trial tests whether immediate or selective re-irradiation after a good response to PD-1 inhibitor plus gemcitabine-cisplatin helps people with locally advanced recurrent nasopharyngeal carcinoma live longer with acceptable side effects.
-
Combining EGFR antibody, PD-1 inhibitor, and chemotherapy for advanced nasopharyngeal carcinoma
This study tests a new combination of treatments using an EGFR antibody, a PD-1 inhibitor, and chemotherapy to see if it helps people with advanced nasopharyngeal carcinoma feel better compared to standard options.
Related topics
Quick answers
How many Recurrent Nasopharynx Carcinoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.